Our doctors and co-founders, Dr. Michael Dattoli and Dr. Richard Sorace, are world-renowned experts in prostate cancer treatment and care. Each has as much experience, if not more, than any prostate brachytherapist in the world. Together they represent nearly four decades of prostate-specific research and practice. As a result of the years they have dedicated to caring for prostate cancer patients, they posess an unmatched level of proficiency and skill attained through treating prostate cancer in all its manifestations. This knowledge, backed by their constant quest to refine and perfect non-surgical treatment methods, is what sets this center apart and draws patients to it from all over the world.
These two specialists trained at some of the most highly regarded cancer research facilities in the world. Michael Dattoli, MD, attended the University of California at Berkeley and was the Valedictorian of his class at Vassar College; he earned his medical degree at Mount Sinai School of Medicine, Radiation Oncology at New York University Medical Center, then distinguished himself at Memorial Sloan-Kettering Cancer Center and New York Hospital-Cornell University Medical Center, as the Special Fellow in Brachytherapy. He was appointed. Associate Professor in Brachytherapy and Radiation Oncology at Memorial Sloan- Kettering Cancer Center in New York and at New York Hospital-Cornell University Medical Center prior to relocating to Florida. He was selected by the International Association of Oncologists as a Leading Physician of the World and top Brachytherapist.
Richard Sorace, MD, PhD, is board-certified in radiation oncology, medical oncology and internal medicine. He also has a PhD in Pharmacology. Dr. Sorace has extensive background in the multimodal approach to cancer treatment and has published original work in this field. He has been key in the development of Dattoli’s proven combined modality approach, and heads the Center’s research division. He received his Bachelor’s degree in Science from Rensselear Polytechnic Institute in New York, and his Medical Doctorate degree, as well as PhD, from SUNY Downstate Medical Center. He completed his Internal Medicine residency at the University of Chicago, then his Radiation Oncology residency and Medical Oncology fellowship at the National Cancer Institute.